MedTrace Logo

Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Patients With Thoracic Spinal Cord Injury

NCT01321333 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2015-06-18

No results posted yet for this study

Summary

This study will evaluate the effect of single transplantation of HuCNS-SC cells into the thoracic spinal cord of patients with sub-acute spinal cord injury.

Conditions

  • Thoracic Spinal Cord Injury
  • Spinal Cord Injury
  • Spinal Cord Injury Thoracic
  • Spinal Cord Trauma

Interventions

BIOLOGICAL

HuCNS-SC cells

single dose intramedullary transplantation of HuCNS-SC cells in the thoracic spinal cord

Sponsors & Collaborators

  • StemCells, Inc.

    lead INDUSTRY

Principal Investigators

  • Stephen Huhn, MD · StemCells, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • Canada
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01321333 on ClinicalTrials.gov